The big bet on luxury stocks stumbles on inflation
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows - Bloomberg
Novo Nordisk CEO spies new pharmaceutical sales model — MedWatch
All eyes on US payrolls as dollar eases, oil gains
Novo Nordisk briefly eclipses LVMH as Europe's most valuable company
Novo Nordisk Becomes Europe's Most Valuable Company
Eli Lilly, Novo to lead $100B weight loss drug market in 2030: JPMorgan
Nick Humphries on LinkedIn: I once had a proper chat with Manchester United's former assistant.. and…
Novo Nordisk, maker of Ozempic, unseats LVMH as European stock market's largest company
Money Archives - Page 45 of 100 - KTVZ
Archil Tediashvili - Investment Banking Analyst - TBC Capital
Whatever Happened To European Corporate Competitors?
Novo Nordisk HealthCare Middle East & Africa Magazine